Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients.

Kang SG, Lee HJ, Yoon HK, Cho SN, Park YM, Kim L.

Nord J Psychiatry. 2013 Jun;67(3):214-8. doi: 10.3109/08039488.2012.732114. Epub 2012 Nov 6.

PMID:
23126479
2.

No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.

Lee HJ, Kang SG, Choi JE, Paik JW, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Neuropsychobiology. 2007;55(1):47-51. Epub 2007 Jun 8.

PMID:
17556853
3.

Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.

Woo SI, Kim JW, Rha E, Han SH, Hahn KH, Park CS, Sohn JW.

Psychiatry Clin Neurosci. 2002 Aug;56(4):469-74.

4.

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.

Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Petronis A, Kennedy JL.

Mol Psychiatry. 2001 Mar;6(2):230-4.

5.

Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.

Park SW, Lee JG, Kong BG, Lee SJ, Lee CH, Kim JI, Kim YH.

Psychiatry Clin Neurosci. 2009 Aug;63(4):433-9. doi: 10.1111/j.1440-1819.2009.01976.x. Epub 2009 Apr 27.

6.

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.

Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, Dorevitch A, Yakir A, Greenberg D, Lerner A, Lerer B.

Mol Psychiatry. 2001 Mar;6(2):225-9.

7.

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.

Zai CC, Hwang RW, De Luca V, Müller DJ, King N, Zai GC, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL.

Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51. Epub 2006 Sep 7.

PMID:
16959057
8.

Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.

Liou YJ, Wang YC, Chen JY, Bai YM, Lin CC, Liao DL, Chen TT, Chen ML, Mo GH, Lai IC.

Psychiatry Res. 2007 Dec 3;153(3):271-5. Epub 2007 Jul 31.

PMID:
17669510
9.

No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.

Lee HJ, Kang SG, Paik JW, Lee MS, Cho BH, Park YM, Kim W, Choi JE, Jung IK, Kim L, Lee MS.

Hum Psychopharmacol. 2007 Dec;22(8):501-4.

PMID:
17726725
10.

Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.

Lai IC, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY, Wang YC.

Neuropsychobiology. 2002;46(4):173-5.

PMID:
12566932
11.

Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.

Liou YJ, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Mo GH, Lai IC.

Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):239-42. doi: 10.1002/ajmg.b.30796.

PMID:
18548510
12.
14.

Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.

Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.

Acta Pharmacol Sin. 2006 Mar;27(3):328-32.

15.

Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.

Pae CU, Yu HS, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH.

Int J Neuropsychopharmacol. 2004 Dec;7(4):495-500. Epub 2004 May 20.

PMID:
15151706
16.

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.

Kang SG, Choi JE, An H, Lim SW, Lee HJ, Han C, Kim YK, Kim SH, Cho SN, Lee MS, Joe SH, Jung IK, Kim L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1545-8. doi: 10.1016/j.pnpbp.2008.05.016. Epub 2008 May 29.

PMID:
18602732
17.

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.

Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, Lerer B, Nimagaonkar VL, Thelma BK.

Pharmacogenomics J. 2005;5(1):60-9.

PMID:
15505641
18.

Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.

Chong SA, Tan EC, Tan CH, Mythily, Chan YH.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):51-4.

PMID:
12497614
19.

Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.

Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, Yakir A, Greenberg D, Strous R, Lerner A, Shelevoy A, Lerer B.

Pharmacogenomics J. 2003;3(5):277-83.

PMID:
14583797
20.

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL.

Mol Psychiatry. 2000 Jul;5(4):410-7.

PMID:
10889552
Items per page

Supplemental Content

Write to the Help Desk